BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 202 SEK -5.08% Market Closed
Market Cap: 17.8B SEK
Have any thoughts about
BioArctic AB?
Write Note

Wall Street
Price Targets

BIOA B Price Targets Summary
BioArctic AB

There are no price targets for BIOA B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioArctic AB Competitors:
Price Targets
IMTX
Immatics NV
138% Upside
4599
StemRIM Inc
145% Upside
214450
PharmaResearch Co Ltd
8% Upside
377740
BioNote Inc
20% Upside
AUPH
Aurinia Pharmaceuticals Inc
24% Upside
IDYA
IDEAYA Biosciences Inc
124% Upside
ALVO
Alvotech SA
65% Upside
NVAX
Novavax Inc
108% Upside

Revenue
Forecast

Revenue Estimate
BioArctic AB

For the last 7 years the compound annual growth rate for BioArctic AB's revenue is 29%. The projected CAGR for the next 4 years is 46%.

29%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioArctic AB

For the last 7 years the compound annual growth rate for BioArctic AB's operating income is 23%. The projected CAGR for the next 4 years is 67%.

23%
Past Growth
67%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
BioArctic AB

For the last 7 years the compound annual growth rate for BioArctic AB's net income is 22%. The projected CAGR for the next 4 years is 56%.

22%
Past Growth
56%
Estimated Growth
Estimates Accuracy
4%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOA B's stock price target?
Not Available

BIOA B doesn't have any price targets made by Wall Street professionals.

What is BioArctic AB's Revenue forecast?
Projected CAGR
46%

For the last 7 years the compound annual growth rate for BioArctic AB's revenue is 29%. The projected CAGR for the next 4 years is 46%.

What is BioArctic AB's Operating Income forecast?
Projected CAGR
67%

For the last 7 years the compound annual growth rate for BioArctic AB's operating income is 23%. The projected CAGR for the next 4 years is 67%.

What is BioArctic AB's Net Income forecast?
Projected CAGR
56%

For the last 7 years the compound annual growth rate for BioArctic AB's net income is 22%. The projected CAGR for the next 4 years is 56%.

Back to Top